Kriya Therapeutics
llan Oren has served as Director of Roivant since 2014. He has served as Co-Chief Executive Officer of Dexcel Pharma, a privately-owned Israeli group of pharmaceutical companies, since November 2019. Ilan is currently on the board of Clexio Biosciences. Prior to serving as Co-CEO, llan served as Vice President for the group and led corporate and business development activities, including the formation of strategic ventures, product partnerships, product portfolio selection, product acquisitions, strategic investments, and mergers and acquisitions. He holds an A.B. in Economics from Harvard College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Kriya Therapeutics
2 followers
Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs.